Cyclerion Therapeutics Inc (CYCN)
3.04
+0.21
(+7.42%)
USD |
NASDAQ |
May 01, 16:00
3.04
0.00 (0.00%)
After-Hours: 17:50
Cyclerion Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | 0.072M |
| March 31, 2022 | 0.225M |
| December 31, 2021 | 0.182M |
| September 30, 2021 | 0.077M |
| June 30, 2021 | 3.00M |
| March 31, 2021 | 0.062M |
| December 31, 2020 | 0.133M |
| Date | Value |
|---|---|
| September 30, 2020 | 0.40M |
| June 30, 2020 | 0.749M |
| March 31, 2020 | 1.014M |
| December 31, 2019 | 1.481M |
| September 30, 2019 | 1.398M |
| June 30, 2019 | 1.628M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.062M
Minimum
Mar 2021
3.00M
Maximum
Jun 2021
0.8016M
Average
0.40M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
| Eli Lilly and Co | 9.353B |
| iBio Inc | -- |
| AbbVie Inc | 12.31B |
| Agile Therapeutics Inc | 3.614M |
| NovaBay Pharmaceuticals Inc | 3.727M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.694M |
| Total Expenses (Quarterly) | 1.795M |
| EPS Diluted (Quarterly) | -0.70 |
| Enterprise Value | 0.0986M |
| Earnings Yield | -99.01% |
| Normalized Earnings Yield | -782.99 |